Auzone Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
3
Auzone General Information
Description
Developer of pharmaceutical drugs designed to treat central nervous system and autoimmune diseases. The company's technology focuses on the development of antioxidant neuroprotectants and small molecule drugs for neurodegenerative conditions, enabling healthcare providers to offer oral treatment options for acute ischemic stroke and amyotrophic lateral sclerosis.
Contact Information
Website
www.auzonebio.comCorporate Office
- 19F, Binjiang Smart Plaza
- Number 1366 Yangshupu Road, Yangpu District
- Suzhou, Jiangsu 200082
- China
Corporate Office
- 19F, Binjiang Smart Plaza
- Number 1366 Yangshupu Road, Yangpu District
- Suzhou, Jiangsu 200082
- China
Auzone Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Auzone Signals
Auzone Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Auzone FAQs
-
When was Auzone founded?
Auzone was founded in 2017.
-
Where is Auzone headquartered?
Auzone is headquartered in Suzhou, China.
-
What is the size of Auzone?
Auzone has 6 total employees.
-
What industry is Auzone in?
Auzone’s primary industry is Drug Discovery.
-
Is Auzone a private or public company?
Auzone is a Private company.
-
What is Auzone’s current revenue?
The current revenue for Auzone is .
-
Who are Auzone’s investors?
Beijing Jinhuifeng Investment Management and Suzhou Guanghua Industry (Group) have invested in Auzone.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process